Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
In recent transactions reported to the Securities and Exchange Commission, Marlan D. Walker, the Chief Executive Officer of TherapeuticsMD, Inc. (NASDAQ:TXMD), acquired additional shares of the company's common stock. Walker purchased a total of 2,303 shares over two days, with a total transaction value of approximately $1,994. Insider transactions can provide valuable insights into management's confidence in the company's prospects. For detailed analysis of insider trading patterns and comprehensive financial metrics, consider subscribing to InvestingPro.
On April 9, Walker acquired 1,136 shares at a weighted average price of $0.8747 per share. The transaction was conducted through multiple purchases, with prices ranging from $0.8741 to $0.88 per share. On the following day, April 10, he purchased an additional 1,167 shares at a price of $0.8572 per share. Track real-time price movements and access advanced technical analysis tools with InvestingPro.
Following these transactions, Walker now directly owns 73,149 shares of TherapeuticsMD. These purchases reflect his ongoing investment in the company, which is based in Boca Raton, Florida, and specializes in pharmaceutical preparations. The pharmaceutical sector has seen significant insider activity recently, suggesting potential opportunities in the space.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.